ALPHA 1 ANTITRYPSIN DEFICIENCY AUGMENTATION THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Drug (Glassia, Aralast NP, Prolastin C, Trypsone, Zemaira, and Late Phase Drug), By Route of Administration (Inhalational and Injections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 17 Apr, 2026
Code: CMI9440
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Drug
  - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Route of Administration
  - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Distribution Channel
  - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Drug, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Glassia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Aralast NP
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Prolastin C
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Trypsone
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Zemaira
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Late Phase Drug
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Inhalational
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Injections
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Drug, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Grifols S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CSL Behring
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kamada Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Baxter International Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- LFB Biotechnologies
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AstraZeneca plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Arrowhead Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vertex Pharmaceuticals Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now